Lebwohl, Mark, Andrew Blauvelt, Alan Menter, Kim Papp, and Abby Jacobson. 2019. “Long-Term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab”. SKIN The Journal of Cutaneous Medicine 3 (November):S26. https://doi.org/10.25251/skin.3.supp.26.